Wildcat Capital Management, LLC - Jun 26, 2025 SCHEDULE 13D/A Report for Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share (SLXN)

Filing Manager
Wildcat Capital Management, LLC
Reporting Manager
Wildcat Capital Management, LLC
Security
Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share
Symbol
SLXN
Shares outstanding
8.73M shares
Disclosed Ownership
113K shares
Ownership
1.3%
Form type
SCHEDULE 13D/A
Date filed
6/26/2025, 04:15 PM
Date of event
Jun 26, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Wildcat Capital Management, LLC 1.3% 113K 0 113K /s/Leonard A. Potter Leonard A. Potter/President 0001582384
Wildcat Partner Holdings, LP 1.3% 113K 0 113K /s/Sherri Conn Sherri Conn/Vice President 0001633223
Leonard A. Potter 1.3% 113K 0 113K /s/Leonard A. Potter Leonard A. Potter 0001476217